Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Markus Raderer

Showing results (171-180 of 264) with videos related to

Pageof 27
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 19, 2005
Phase II study of oxaliplatin for treatment of patients with mucosa-associated lymphoid tissue lymphomaMarkus Raderer, Stefan Wöhrer, Rupert Bartsch, et al.
Hematological Oncology|August 29, 2018
Treatment of mucosa associated lymphoid tissue lymphoma with a long-term once-weekly regimen of oral azithromycin: Results from the phase II MALT-A trialHeimo Lagler, Barbara Kiesewetter, Werner Dolak, et al.
Haematologica|November 27, 2025
Complete remission of bronchus-associated lymphoid tissue lymphoma after antibiotic treatment for Tropheryma whippleiTeresa Antonia Kiener, Gregor Schweighofer-Zwink, Gundula Rendl, et al.
ESMO Open|August 2, 2017
The European Society for Medical Oncology 'Magnitude of Clinical Benefit Scale' field-tested in infrequent tumour entities: an extended analysis of its feasibility at the Medical University of ViennaBarbara Kiesewetter, Markus Raderer, Gerald W Prager, et al.
Leukemia & Lymphoma|September 25, 2014
The potential evasion of immune surveillance in mucosa associated lymphoid tissue lymphoma by DcR2-mediated up-regulation of nuclear factor-κBMariam Anees, Peter Horak, Ana-Iris Schiefer, et al.
JACC. Case Reports|March 28, 2025
Simultaneous Transcatheter Pulmonary and Tricuspid Valve Replacement in Carcinoid Heart DiseaseVarius Dannenberg, Caglayan Demirel, Markus Raderer, et al.
Clinical Nuclear Medicine|June 5, 2023
68Ga-Pentixafor PET/MRI for Treatment Response Assessment in Mantle Cell Lymphoma: Comparison Between Changes in Lesion CXCR4 Expression on PET and Lesion Size and Diffusivity on MRIMarius E Mayerhoefer, Markus Raderer, Michael Weber, et al.
The Journal of Clinical Investigation|May 3, 2003
Vasoactive intestinal peptide as a new drug for treatment of primary pulmonary hypertensionVentzislav Petkov, Wilhelm Mosgoeller, Rolf Ziesche, et al.
World Journal of Surgery|May 7, 2003
Resection of hilar cholangiocarcinomas: pivotal prognostic factors and impact of tumor sclerosisHarald Puhalla, Thomas Gruenberger, Herwig Pokorny, et al.
Plos One|October 11, 2016
Evaluation of [18F]-FDG-Based Hybrid Imaging Combinations for Assessment of Bone Marrow Involvement in Lymphoma at Initial StagingUlrika Asenbaum, Richard Nolz, Georgios Karanikas, et al.
Pageof 27

Showing results (171-180 of 264) with videos related to

Sort By:
Pageof 27
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 19, 2005
Phase II study of oxaliplatin for treatment of patients with mucosa-associated lymphoid tissue lymphomaMarkus Raderer, Stefan Wöhrer, Rupert Bartsch, et al.
Hematological Oncology|August 29, 2018
Treatment of mucosa associated lymphoid tissue lymphoma with a long-term once-weekly regimen of oral azithromycin: Results from the phase II MALT-A trialHeimo Lagler, Barbara Kiesewetter, Werner Dolak, et al.
Haematologica|November 27, 2025
Complete remission of bronchus-associated lymphoid tissue lymphoma after antibiotic treatment for Tropheryma whippleiTeresa Antonia Kiener, Gregor Schweighofer-Zwink, Gundula Rendl, et al.
ESMO Open|August 2, 2017
The European Society for Medical Oncology 'Magnitude of Clinical Benefit Scale' field-tested in infrequent tumour entities: an extended analysis of its feasibility at the Medical University of ViennaBarbara Kiesewetter, Markus Raderer, Gerald W Prager, et al.
Leukemia & Lymphoma|September 25, 2014
The potential evasion of immune surveillance in mucosa associated lymphoid tissue lymphoma by DcR2-mediated up-regulation of nuclear factor-κBMariam Anees, Peter Horak, Ana-Iris Schiefer, et al.
JACC. Case Reports|March 28, 2025
Simultaneous Transcatheter Pulmonary and Tricuspid Valve Replacement in Carcinoid Heart DiseaseVarius Dannenberg, Caglayan Demirel, Markus Raderer, et al.
Clinical Nuclear Medicine|June 5, 2023
68Ga-Pentixafor PET/MRI for Treatment Response Assessment in Mantle Cell Lymphoma: Comparison Between Changes in Lesion CXCR4 Expression on PET and Lesion Size and Diffusivity on MRIMarius E Mayerhoefer, Markus Raderer, Michael Weber, et al.
The Journal of Clinical Investigation|May 3, 2003
Vasoactive intestinal peptide as a new drug for treatment of primary pulmonary hypertensionVentzislav Petkov, Wilhelm Mosgoeller, Rolf Ziesche, et al.
World Journal of Surgery|May 7, 2003
Resection of hilar cholangiocarcinomas: pivotal prognostic factors and impact of tumor sclerosisHarald Puhalla, Thomas Gruenberger, Herwig Pokorny, et al.
Plos One|October 11, 2016
Evaluation of [18F]-FDG-Based Hybrid Imaging Combinations for Assessment of Bone Marrow Involvement in Lymphoma at Initial StagingUlrika Asenbaum, Richard Nolz, Georgios Karanikas, et al.
Pageof 27